CHIGENOVO

Changping District, China Founded: 2016 • Age: 10 yrs
Gene therapy drugs for inherited eye diseases are developed.

About CHIGENOVO

CHIGENOVO is a company based in China founded in 2016.. CHIGENOVO has raised $26.45 million across 3 funding rounds from investors including Kunlun Capital, Gimpo Investment and Yingke Capital. CHIGENOVO offers products and services including Gene Therapy Drugs and Gene Diagnosis Services.

  • Headquarter Changping District, China
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name 北京中因科技有限公司
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $26.45 M (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CHIGENOVO

CHIGENOVO offers a comprehensive portfolio of products and services, including Gene Therapy Drugs and Gene Diagnosis Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Gene therapy drugs for hereditary eye diseases are developed and evaluated.

Precise genetic diagnosis for eye diseases is offered through sequencing and analysis.

Funding Insights of CHIGENOVO

CHIGENOVO has successfully raised a total of $26.45M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (23 Mar 2021)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2023 Amount Series A - CHIGENOVO Valuation Kunlun Capital
Mar, 2022 Amount Series A - CHIGENOVO Valuation

investors

Mar, 2021 Amount Seed - CHIGENOVO Valuation Longmen Capital , Lotus Lake Capital Management
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CHIGENOVO

CHIGENOVO has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kunlun Capital, Gimpo Investment and Yingke Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments in technology companies are managed by Kunlun Capital.
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CHIGENOVO

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CHIGENOVO

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Chigenovo Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CHIGENOVO

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Chigenovo

Frequently Asked Questions about CHIGENOVO

When was CHIGENOVO founded?

CHIGENOVO was founded in 2016 and raised its 1st funding round 5 years after it was founded.

Where is CHIGENOVO located?

CHIGENOVO is headquartered in China. It is registered at Beijing, China.

Is CHIGENOVO a funded company?

CHIGENOVO is a funded company, having raised a total of $26.45M across 3 funding rounds to date. The company's 1st funding round was a Seed of $10.75M, raised on Mar 23, 2021.

What does CHIGENOVO do?

CHIGENOVO was founded in 2016 and is located in Changping District, China. Operations are centered in the biotechnology sector, where gene therapy drugs for inherited eye diseases are developed alongside genetic diagnosis services. Focus is placed on high-tech advancements to address these conditions through innovative therapeutic and diagnostic approaches. The company operates as a specialized enterprise in this niche.

What products or services does CHIGENOVO offer?

CHIGENOVO offers Gene Therapy Drugs and Gene Diagnosis Services.

Who are CHIGENOVO's investors?

CHIGENOVO has 7 investors. Key investors include Kunlun Capital, Gimpo Investment, Yingke Capital, Huayi Capital, and Junci Investment.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available